-advertisment-
Health

Time: 2024-07-08

New Alzheimer's Drug: Hope for Patients and Caregivers

New Alzheimer's Drug: Hope for Patients and Caregivers
-advertisment-

Health Stories You Need to Know About

Fox News Digital delivers a variety of health content weekly , covering disease prevention , nutrition , medical research , and Health care . They also share stories of individuals overcoming health challenges . If you want to stay updated on the latest health news , Fox News Health is the place to be.

This week , some of the top stories include a case of human plague in Colorado , a man with epilepsy using painted seashells to raise awareness , and the FDA approving a new drug for Alzheimer 's disease . Caregivers for Alzheimer 's patients also received tips on how to manage caregiver stress . Additionally , common questions women over 40 ask their doctors were addressed , and the dangers of DIY drugs were highlighted.

New Alzheimer's Drug: Hope for Patients and Caregivers

New Alzheimer 's Drug Approved by FDA

Eli Lilly 's new Alzheimer 's drug , Kisunla ( donanemab ) , has been approved by the FDA for adults with early symptomatic Alzheimer 's disease . The drug , given as a monthly injection , targets amyloid proteins in the brain to slow the progression of the disease . The approval offers hope to Alzheimer 's patients and caregivers by providing more treatment options.

Complicated News on Weight Loss Drugs

Recent research has shown that GLP-1 medications , such as semaglutide , may reduce the risk of obesity - associated cancers but could also be linked to a rare eye condition called NAION . Long - term studies are needed to confirm the benefits and risks of these medications . Patients taking GLP-1 medications should be aware of potential side effects and seek medical help if they experience vision problems.

Health Risks of Microdosing Candies

Federal health officials are investigating illnesses and a possible death linked to microdosing candies containing muscimol , a psychoactive chemical found in amanita mushrooms . Consumers should be cautious when using these products , as they are not well - regulated , and more research is needed to understand the risks . If you have these products , it is advised to stop using them immediately to avoid potential health complications.

-advertisment-
-advertisment-
-advertisment-